Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PMVP compared with PLRX: revenue, margins and what each company keeps, and the suppliers and customers both name
PMVP
PMV Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
PLRX
Pliant Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PMVP
PMV Pharmaceuticals, Inc.
vs
PLRX
Pliant Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PMVP
1
—
Foundation Medicine
unlisted
supplier
Shared
0
No shared counterparties.
Only PLRX
1
NVS
Novartis
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
PMVP
PMV Pharmaceuticals, Inc.
Change
1.27
▼
−4.15%
· post 1.27
Mkt cap
$70.8M
Revenue
—
PLRX
Pliant Therapeutics, Inc.
Change
0.81
▼
−4.77%
· post 0.81
Closed
Nov 5 '26
Mkt cap
$52.7M
Revenue
$248,000
Q2 FY23
vs
Compare
Closed
Nov 5 '26
PMVP
PMV Pharmaceuticals, Inc.
vs
PLRX
Pliant Therapeutics, Inc.
1.27
▼
−4.15%
post 1.27
Price
0.81
▼
−4.77%
post 0.81
$70.8M
Mkt cap
$52.7M
—
Revenue
$248,000
Q2 FY23
Change
Change
PMVP
1.27
▼
−4.15%
vs
PLRX
0.81
▼
−4.77%
Closed
Nov 5 '26